Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach Fatemeh Bazarganipour,

Slides:

Advertisements

Similar presentations

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Advertisements

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.

Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice Lysanne.

Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D.

Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome Michel De Vos,

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome Anuja Dokras, M.D., Ph.D., Shailly Saini,

Developmental capacity of in vitro–matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm Luis.

Akanksha Mehta, M.D., Mark Sigman, M.D. Fertility and Sterility

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.

Edward G. Hughes, M.B., F.R.C.S.(C.), Deirdre DeJean, M.Sc.

Infertility evaluation and treatment among women in the United States

Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D

Thyroid antibodies and gestational diabetes mellitus: a meta-analysis

Michael M. Alper, M.D. Fertility and Sterility

Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome Anuja Dokras, M.D., Ph.D., Shailly Saini,

Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study Cem Celik, M.D., Nicel.

Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome

Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,

Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study Angela Kerchner, B.A., Whitney Lester,

Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women.

Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system Shan Liu, M.D.,

Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature.

Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary.

Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary.

CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype

Iris G. Insogna, M. D. , Malinda S. Lee, M. D. , M. B. A. , Rebecca M

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Oocyte cryopreservation

Evolutionary determinants of polycystic ovary syndrome: part 1

Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized.

Klinefelter's syndrome with unilateral absence of vas deferens

Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis

Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.

Reply of the Authors Fertility and Sterility

Gadolinium radiologic contrast is a useful alternative for hysterosalpingography in patients with iodine allergy Dorette Noorhasan, M.D., Michael J.

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Evaluation of diagnostic testis biopsy and the repetition of testicular sperm extraction surgeries in infertility patients Alayman Hussein, M.B.B.C.H.,

Increased secretion of amylin in women with polycystic ovary syndrome

The forgotten coil Fertility and Sterility

Antoni J. Duleba, M.D., Ibrahim M. Ahmed, M.D. Fertility and Sterility

Atsushi Yanaihara, M. D. , Ph. D. , Takeshi Yorimitsu, M. D

Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment Richard Fleming, Ph.D.,

Banu Ucar, M. D. , Volkan Noyan, M. D. , Osman Caglayan, M. D

Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial Antoni J. Duleba, M.D.,

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Lindsay M. Mains, M. D. , Babak Vakili, M. D. , Yves Lacassie, M. D

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Fertility and Sterility: an evaluation

Paolo Moghetti, M.D. Fertility and Sterility

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,

Ovarian cystic teratoma with a pathognomonic appearance of multiple floating balls: a case report and investigation of common characteristics of the cases.

Current evaluation of amenorrhea

Genetic evaluation procedures at sperm banks in the United States

A simplified novel laparoscopic formation of neovagina for cases of Mayer-Rokitansky- Küster-Hauser syndrome Atef Mohammad Darwish, M.D. Fertility and.

Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients Artemis Karkanaki,

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels

Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis

Maternal serum screening markers and nuchal translucency measurements in in vitro fertilization pregnancies: a systematic review Andrea Lanes, M.Sc.,

Presentation transcript:

Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach Fatemeh Bazarganipour, M.Sc., Saeide Ziaei, M.D., Ali Montazeri, Ph.D., Fatemeh Foroozanfard, M.D., Anoshirvan Kazemnejad, Ph.D., Soghrat Faghihzadeh, Ph.D. Fertility and Sterility Volume 100, Issue 5, Pages 1389-1396.e3 (November 2013) DOI: 10.1016/j.fertnstert.2013.06.043 Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Conceptual model of health-related quality of life (HRQOL) in polycystic ovary syndrome patients. Fertility and Sterility 2013 100, 1389-1396.e3DOI: (10.1016/j.fertnstert.2013.06.043) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Supplemental figure 1 Structural equation model for the hyperandrogenism with polycystic ovaries in ultrasonography phenotype. Only significant pathways are presented (t >1.96). The numbers in parentheses indicate 95% confidence intervals. HRQOL = health-related quality of life. Fertility and Sterility 2013 100, 1389-1396.e3DOI: (10.1016/j.fertnstert.2013.06.043) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Supplemental figure 2 Structural equation model for the irregular menstruation with polycystic ovaries in ultrasonography phenotype. Only significant pathways are presented (t >1.96). The numbers in parentheses indicate 95% confidence intervals. HRQOL = health-related quality of life. Fertility and Sterility 2013 100, 1389-1396.e3DOI: (10.1016/j.fertnstert.2013.06.043) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Supplemental figure 3 Structural equation model for the hyperandrogenism with irregular menstruation with or without polycystic ovaries in ultrasonography phenotype. Only significant pathways are presented (t >1.96). The numbers in parentheses indicate 95% confidence intervals. HRQOL = health-related quality of life. Fertility and Sterility 2013 100, 1389-1396.e3DOI: (10.1016/j.fertnstert.2013.06.043) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions